Impact of limitations on the use of tax-advantaged accounts for the purchase of over-the-counter medication  hearing before the Subcommittee on Oversight of the Committee on Ways and Means, U.S. House of Representatives, One Hundred Twelfth Congress, second session, April 25, 2012. 

 - iii, 82 pages  illustrations  24 cm 
<br/><br/> Shipping list no.: 2013-0229-P.  "Serial no. 112-OS11." 
<br/><br/>Includes bibliographical references. 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Drugs, Nonprescription--Prices--United States.<br/>Income tax deductions for medical expenses--United States.
<br/><br/><label>LC Class. No.: </label>KF27  / .W345 2012 
<br/><br/><label>GPO Item No.: </label>1028-A 1028-C (online) 
<br/><br/><label>Gov. Doc. Class. No.: </label>Y 4.W 36:112-OS 11 
<br/><br/><label>Report. No.: </label>Serial no. 112-OS11 (United States. Congress. House. Committee on Ways and Means)